AMENDMENT #3 TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • February 14th, 2024 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment #3 to Convertible Promissory Note (this “Amendment”) is entered into as of February 9, 2024, by and between STREETERVILLE CAPITAL, LLC, a Utah limited liability company (“Lender”), and NRX PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below), Amendment #1 (as defined below) and Amendment #2 (as defined below).
